Comments on: Q3 Is Looking Up for Biotech: Emdeon, Cumberland, Domain, LOM BioQuest, OETF

By: Is the IPO Window Open for Biotech and Pharma? Talecris and Anthera Aim to Find Out. « The Cross-Border Biotech Blog

Thu, 17 Sep 2009 03:10:06 +0000

[...] · Leave a Comment Biopharma IPOs come in pairs, apparently (a-pair-ently?). A month ago, Cumberland and Emdeon created something that looked like an IPO window and now, Talecris Biotherapeutics and Anthera Pharmaceuticals have filed to go [...]

By: Interview With Garrett Herman Yeilds More Detail on the LOM-BioQuest Joint Venture « The Cross-Border Biotech Blog

Tue, 18 Aug 2009 16:56:15 +0000

[...] 18, 2009 · Leave a Comment We have new details about the LOM-BioQuest joint venture that was announced last week. The WSJ article about the JV emphasized the goals of supporting good science and expanding the [...]

By: Monday Deal Review: August 17, 2009 « The Cross-Border Biotech Blog

Monday Deal Review: August 17, 2009 « The Cross-Border Biotech Blog — Mon, 17 Aug 2009 11:07:22 +0000

[...] 17, 2009 · Leave a Comment In addition to the highlights already noted — Enobia’s $50 million r0und, and the LOM – BioQuest joint venture — there was plenty of other Canadian deal activity this week. Check it [...]